TherapeuticsMD (TXMD) Divestments (2010 - 2022)
TherapeuticsMD's (TXMD) quarterly Divestments came in at $223.8 million in Q4 2022, up 168355.64% quarter-over-quarter from -$133000.0 in Q3 2022.
Powered by 
Analysis
TherapeuticsMD (TXMD) Divestments (2010 - 2022) Analysis & Trends
TherapeuticsMD (TXMD) has reported Divestments for 2 consecutive years, with $223.8 million the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Divestments changed N/A year-over-year to $223.8 million; the trailing twelve-month figure through Dec 2023 stood at $223.6 million (changed 0.08% YoY), and the FY2022 full-year result was $223.8 million, changed N/A from the prior year.
- Divestments rose to $223.8 million in Q4 2022 per TXMD's latest filing, from -$133000.0 in the prior quarter.
- Across five years, Divestments topped out at $223.8 million in Q4 2022 and bottomed at -$119.8 million in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 62.00 Mn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 1.88 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 209.00 Mn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 223.78 Mn |
| Sep 30, 2022 | -133,000.00 |
| Jun 30, 2022 | -119.81 Mn |
| Mar 31, 2022 | 120.00 Mn |
| Sep 30, 2010 | -72,000.00 |